PharmaTalkRadio

In this podcast from DPharm 2018, Bayer shares how they use virtual assistants and chatbots to support study teams, research sites, and patients. Learn how they are doing this and what you should consider.

Speaker: Michelle Shogren, Head of Innovation, Portfolio & Operations, Bayer

The 9th annual DPharm conference will take place on September 17-18 in Boston, MA. Learn more at theconferenceforum.org.

In this podcast, Valerie Bowling, Director of DPharm, walks you through what to expect at DPharm 2019 in under 5 minutes. This is the 9th annual DPharm conference featuring keynotes from:

Dr Scott Gottlieb, 23rd Commissioner of the FDATakeda’s CMO, Dr Andy PlumpMerck’s VP of Global Operations, Dr Mark TraversCellarity's Chief Data Officer, Milind KamkolkarStarbucks' Design Director of Global Digital Products, Robert MercerFast Company's Deputy Editor, David LidskyHealthgrades' Founder, Kerry HicksRadio City Rockette and Patient Advocate, Alyssa Epstein

All of this plus: pharma reporting from the trenches, multiple track choices, opportunities to meet patients, and more.

The 9th annual DPharm will take place on September 17-18 in Boston, MA. Learn more at theconferenceforum.org

Trialspark, CEO, Dr Ben Liu recently sat down with Valerie Bowling, Executive Director of DPharm in a podcast discussion.  Valerie checked in with Ben on the progress of life as a data science entrepreneur. They also discussed how Ben and his team are solving big challenges in drug development, new evolving R&D models and more. On Sept 17th, Ben will be interviewing Pfizer's Rod Mackenzie, Chief Development Officer at DPharm: Disruptive Innovations to Advance Clinical Trials in Boston. For more information, please visit theconferenceforum.org

When developing technologies to solve medical problems, one often encounters significant hurdles, that at times seems insurmountable. In this discussion, recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference, Dr Jeffrey Karp, Professor of Medicine, Harvard Medical School and Director of the Laboratory for Accelerated Medical Innovation, Brigham and Women's Hospital discusses overcoming these hurdles with the use of nature for inspiration.

This talk will explore medical technologies being developed that harness lessons from nature for inspiration. Some of the technologies that will be described are rapidly advancing to the clinic and some are already on the market helping patients.

Join us for the 9th annual PODD conference business development event on October 7-8, 2019 at the Renaissance Boston Waterfront Hotel in Boston. PODD covers the latest advances in drug delivery science, while also providing a meeting place to network and form new partnerships.

To learn more about the event, please visit PODD 2019.

In this industry keynote recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference, Justin Wright, PhD, Global Head of Innovation, Novartis, discusses how the transformation from traditional drugs to next-generation product systems, where sometimes the drug is only a component of the overall product offering, is creating a opportunity for non-traditional competitors and start-ups to access the market and potentially redefine the value model associated with drug pricing.

To stay competitive, the pharmaceutical industry’s current business model needs to evolve rapidly from a reactive to a prevention model. At the core of this type of evolved model will be a dynamic patient interface with extraordinary patient engagement. And the delivery system will undoubtedly be a key enabler in the process.

Dr Wright reviews the current and future state with his perspective and cases studies to help shed light on the key areas where focus is needed focus and corresponding opportunities lie.

Join us for the 9th annual PODD conference business development event on October 7-8, 2019 at the Renaissance Boston Waterfront Hotel in Boston. PODD covers the latest advances in drug delivery science, while also providing a meeting place to network and form new partnerships.

To learn more about the event, please visit PODD 2019.

In this podcast from DPharm 2018, Chip Bell shows pragmatic ways to change our culture to support service-oriented thinking that benefits patients and investigators. The patient's expectations are being quickly changed today by disruptors far beyond the Pharma industry. How will the concept of service make us better at drug development and help us become more disruptive thinkers?

Speaker:

Chip Bell, PhD, Keynote Innovative Service Speaker, Author, Senior Partner, The Chip Bell Group

The 9th annual DPharm conference will take place on September 17-18, 2019 in Boston, MA. Learn more at theconferenceforum.org.

Moderated by Marian Gindy, PhD, Executive Director, Discovery Pharmaceutical Sciences, Merck, this panel discussion recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference explores how mRNA vaccines represent a promising alternative to conventional vaccine approaches for infectious diseases as well as oncology indications, including an emerging application for personalized cancer vaccines.

The panelists for the session are:

Örn Almarsson, PhD, Head of Formulations, Moderna TherapeuticsDanilo Casimiro, PhD, VP and Head, External R&D and Vaccine Platforms, SanofiChristian W Mandl, PhD, MD, Chair, Scientific Advisory Board and Co-Founder, Tiba BiotechJinJun Shi, PhD, Associate Professor, Harvard Medical School and Faculty Member, Center for Nanomedicine at Brigham and Women’s HospitalSybil Williams, PhD, Senior Principal Scientist, Personalized Cancer Biology Lead, Merck

Save the date for the 9th annual PODD business development event on October 7-8, 2019 at the Renaissance Boston Waterfront Hotel in Boston. PODD covers the latest advances in drug delivery science, while also providing a meeting place to network and form new partnerships.

To learn more about the event, please visit PODD 2019.

Understanding how to improve drug product design for patients starts with understanding the patient journey. In this discussion recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference, Cornell Stamoran, PhD, VP of Corporate Strategy and Government Affairs, Catalent Pharma Solutions asks patient advocate Alex Rinaudo about his experience as a parent of a son with diabetes.

Diagnosed at 22 months and now aged five, Alex’s son is a typical young, adorable kid. Alex and his wife’s goal is to give him as normal a life as possible in very challenging circumstances. Alex provides his insight on some of the issues they face, such as managing his son’s medications, coordinating the hand-offs in his caregiver network and dealing with other illnesses.

Alex and Cornell also discuss:

- why it’s important to cement self-care behaviors during adolescence and how this affects adulthood

- how the future success of self-care is impacted by the early interactions between parents and children

- what advice Alex would give to product and technology developers

For more insight on the drug delivery industry, please join us for the 9th annual PODD business development event on October 7-8, 2019 at the Renaissance Boston Waterfront Hotel in Boston. PODD covers the latest advances in drug delivery science, while also providing a meeting place to network and form new partnerships.

To learn more about the event, please visit PODD.

This session was presented at the 8th annual DPharm conference in September 2018.

When Amazon announced that the creation of a new healthcare company with Berkshire Hathaway and JPMorgan Chase, the move signaled how the company is stepping into the healthcare industry. However, Amazon Web Services (AWS) has been working directly with the healthcare and life science industries for quite some time. Life Science Director, Mark Johnston, shares how AWS thinks about innovation, in particular for the life science industry, including clinical trials.

More specifically:

How AWS looks at problems and transforms processes through new technologiesHow to think about going faster to be more effective in solving problems without the worries of infrastructureHow to imagine what to do next if you were un-trapped by historical baggage and preceived limitationsOpportunities to considerExamples

Speaker: Mark Johnston, Director of Global Business Development for Health Care, Life Sciences, and Agricultural Technology, Amazon Web Services

The 9th annual DPharm will take place on September 17-18 in Boston, MA. Click here for more information.

Roughly, 5.7 million people in the U.S. are living with Alzheimer’s. Globally, an estimated 47 million individuals are living with dementia. There is no cure, and treatments can only relieve certain symptoms for some people. Research studies so far have a poor record. Patients can face incredible enrollment hurdles in clinical trials. 

A Patient Registry can be very useful in identifying patients. A registry can also address the original problem statement about failed trials. A robust, living registry becomes a data pool from which we can improve both drug discovery, using probabilistic statistics and AI/ML to identify new drug candidates, and drug development, using simulators to predict likelihood of success in Phase 2 or 3.

In this podcast, we discuss major challenges facing developers of Alzheimer’s therapies and address patient registries and how they can improve enrollment and trial design. In this podcast, we will hear some details about the HealthyMindsRegistry, Synexushmr.com and the Protect Study Registry, Protectstudy.org.uk registry. For US and UK citizens over 50 who have not been diagnosed with dementia can participate in the registry on-line.

Guests:

Dr Clive Ballard, Pro-Vice Chancellor and Executive Dean, University of Exeter, External partner in the AES HealthyMinds Registry (HMR)

Dr Heather Bryson, Director, Operational and Strategic Solutions at Accelerated Enrollment Solutions, (AES) 

Host: Dr Julie Adams, Psychiatrist and Regional Medical Officer, PPD Biotech

Producer: Valerie Bowling, Executive Director, the Conference Forum